Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
August 5, 2021     Contact    
Featured This Week
 
Everything Blockchain: Executing Strategy with Rapid Growth Potential
 

 


Everything Blockchain (OTC: OBTX) is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies. Everything Blockchain also designs proprietary security measures and protocols for Blockchain technologies with overlay and licensing revenue opportunities. Utilizing tools within the Blockchain ecosystem to enhance overall performance, the Company continually evaluates new growth opportunities in mining, acquiring, and utilizing cryptocurrencies. Involved in the early-stage launch of HEX, the internet’s first cryptographic certificate of deposit, the Company has earned $5 million of tokens to date and expects to be awarded another $5 million of tokens in the coming months. Staking operations, which can earn interest of 5%-40%, provide Everything Blockchain with additional opportunities for growth and predictable revenue streams. With a highly accomplished management and board, expert team, and access to industry leaders and disruptors, Everything Blockchain is at the forefront of innovative and lead generating technologies.

 
 >
Latest News
 
BioVie (NASDAQ: BIVI) Presents Data Supporting use of NE3107 in the Treatment of Alzheimer's Disease at 2021 Alzheimer's Association International Conference
 >
Virios Therapeutics (NASDAQ: VIRI) Highlights Clinical Sites Fully Operational in Phase 2b Fibromyalgia Study Featuring FDA "Fast Track" Review Designated Antiviral Therapy, Oral IMC-1
 >
Aridis Pharmaceuticals (NASDAQ: ARDS) COVID mAb Ranks Among the Top 5 Most Potent COVID-19 mAbs Evaluated by the Coronavirus Immunotherapeutics Consortium (CoVIC)
 
 
Annovis Bio (NYSE American: ANVS) Presents New Clinical and Biomarker Data at 2021 Alzheimer's Association International Conference
 
 
Annovis Bio (NYSE American: ANVS) Pleased by Positive Interim Results from Ongoing Phase II Clinical Trials of ANVS401 (Posiphen) for the Treatment of Alzheimer's Disease and Parkinson's Disease
 
 
iSpecimen (NASDAQ: ISPC) Launches Enhanced Custom Collection Service
 
 
Kiromic BioPharma (NASDAQ: KRBP) Announces the Acquisition of InSilico Solutions Leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors
 
 
Lantern Pharma (NASDAQ: LTRN) Reacquires Rights to Phase 2 Clinical Trial in Metastatic Prostate Cancer and Global Development & Commercialization of Irofulven (LP-100) from Allarity Therapeutics A/S
 
 
Lantern Pharma (NASDAQ: LTRN) Reports Second Quarter 2021 Financial Results and Operational Highlights
 
 
Draganfly (NASDAQ: DPRO) Announces New CUSIP Number, Consolidation and ISIN Number in connection with Listing on The Nasdaq
 
 
Alset’s (NASDAQ: AEI) American Medical REIT Forges Ahead with Maiden Acquisition of Ivy Brook Medical Center in Connecticut
 
 
Alset EHome International (NASDAQ: AEI) Inks Agreement with Puradigm to Provide Patented Air And Surface Purification Solutions For Its EHome Communities
 
 
Alset EHome International (NASDAQ: AEI) Closes $32 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
 
 
DSS's (NYSE American: DSS) Impact BioMedical to Research Plant-Based Preservation Booster in Collaboration with Thomas Swan Co.
 
 
RYU (OTCQB: RYPPF) Launches/Drops Surprise Limited Edition Collab with Canada Skateboard
 
 
Everything Blockchain (OTC: OBTX) Releases PulseChain Update from its Major Shareholder – Overwatch Partners, Inc.
 
 
Everything Blockchain (OTC: OBTX) Closing Its 4th Strategic Acquisition - Vengar Technologies, LLC
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/84884583902
Or Telephone:
US: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 848 8458 3902
International numbers available:
zoom.us/u/kdthYPvXzZ


 
 
 
 
 

Join Zoom Meeting: zoom.us/j/85760349554
Or iPhone one-tap : US: +13126266799,,85760349554#,,,,*246522#
or +16465588656,,85760349554#,,,,*246522#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 857 6034 9554
Passcode: 246522
International numbers available:
zoom.us/u/kPRtomcXf


 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quote of the Week
 
"Do your homework, understand companies you invest in forwards and backwards."
- Charles Diker, Diker Management-Microcap Superstar
 
 
 
Lesson of the Week
 
Microcap pros make millions by buying before the crowd.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: 3 Under-the-Radar Small-Cap Stocks
 
This week’s episode of the RedChip Money Report features interviews with senior executives from Borqs Technologies (NASDAQ: BRQS), Everything Blockchain (OTC: OBTX), and TFF Pharmaceuticals (NASDAQ: TFFP). Visit RedChip.com to learn more.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Late-Stage Development of First-in-Class Anti-Infectives
 
Aridis Pharmaceuticals (Nasdaq: ARDS) is a late-stage clinical development company, leading the creation of transformative, first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections. The company’s lead drug candidate for acute pneumonia met the primary endpoint for its phase 2 clinical trial and the Company is now enrolling in a global phase 3 study.
 
Watch Now
 
 
 
 
Recruiter.com: Transforming the Recruiting Industry for the Digital Economy
 
Recruiter.com (Nasdaq: RCRT) is a hiring platform for the world’s largest network of recruiters. Recruiter.com empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.
 
Watch Now
 
 
 
 
TFF Pharmaceuticals: Innovative Drug Development using Proprietary Technology Platform
 
TFF Pharmaceuticals (Nasdaq: TFFP) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform.
 
Watch Now
 
 
 
 
Genius Group: Redefining Education in the 21st Century
 
Genius Group’s mission is to develop an entrepreneur education system that prepares students for the 21st Century. Led by founder Roger James Hamilton, a futurist and social entrepreneur, Genius Group is acquiring synergistic companies to strengthen its entrepreneur education curriculum, and in June 2020, Genius Group acquired Entrepreneur Resorts Limited for $32 million.
 
Watch Now
 
 
 
 
Marpai Health: Transforming Health Plan Administration and Improving Patient Outcomes
 
Marpai Health is a leader in deep learning, the most advanced artificial intelligence, and brings the first SMART Health Plan Services System to self-insured companies and their employees to improve health outcomes and reduce healthcare costs.
 
Watch Now
 
 
 
 
Vision Marine: Revolutionizing the Recreational Boating Industry with Electric Power
 
Vision Marine (Nasdaq: VMAR) is the distributer and manufacturer of the world’s fastest electric boat powertrain, the only one capable of reaching 60mph. The company’s ground-breaking E-Motion powertrain is the only truly disruptive series production high powered electric outboard system for watercraft available in the market today.
 
Watch Now
 
 
 
 
Everything Blockchain: Advanced Software Development and Services Solutions
 
Everything Blockchain (OTC: OBTX) is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies. Everything Blockchain also designs proprietary security measures and protocols for Blockchain technologies with overlay and licensing revenue opportunities.
 
Watch Now
 
 
 
 
Draganfly: 20+ Year Leader in Professional Drone Industry
 
Draganfly (OTCQB: DFLYF) has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live.
 
Watch Now
 
 
 
 
Aptorum Group: Drug Development Program Targeting Indications with $250B in Combined Market Value
 
Aptorum Group (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases. In 2021, the company plans to bring two candidates to clinical trials.
 
Watch Now
 
 
 
 
Borqs Technologies: Global Leader in IoT Technology Solutions
 
Borqs (NASDAQ: BRQS) is a global leader in IoT platform and Solutions providing customizable, differentiated and scalable Android-based smart connected devices and cloud service solutions. Borqs has achieved leadership and customer recognition as an innovative end-to-end IoT solutions provider, leveraging its unique strategic chipset partner relationships as well as its broad software and IP portfolio.
 
Watch Now
 
 
 
 
CBD of Denver: Rapidly Growing Distribution Across Europe
 
CBD of Denver (OTC: CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Elys: Interactive Gaming and Sports Betting Technology
 
Elys Game Technology (Nasdaq: ELYS) is a B2B global gaming technology company operating in multiple countries worldwide, with B2C online and land-based gaming operations in Italy. In Italy, Elys offers its clients a full suite of leisure gaming products and services, such as sports betting, e-sports, virtual sports, online casino, poker, bingo, interactive games and slots.
 
Watch Now
 
 
 
 
Hut 8 Mining: HODLing More Self-Mined Bitcoin than any Crypto Miner Globally
 
Hut 8 (Nasdaq: HUT) is one of North America's oldest, largest and innovation-focused bitcoin miners. Hut 8 has one of the highest installed capacity rates in the industry and is #1 globally in held, self-mined Bitcoin of any crypto miner or publicly traded company. Recently ranked 11th (of 10,000) on the 2021 OTCQX® Best 50, and the first publicly traded miner on the TSX, the Hut 8 leadership team is continually looking for ways to accelerate innovation in high performance computing, and the blockchain ecosystem.
 
Watch Now
 
 
 
 
Vision Marine: Transforming the Recreational Boating Industry with Electric Power
 
Vision Marine Technologies (NASDAQ: VMAR) strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power, in turn directly contributing to zero pollution, zero emission and a noiseless environment.
 
Watch Now
 
 
 
 
Nano Dimension: Game Changing Technology with First-to-Market Advantage
 
Nano Dimension (Nasdaq: NNDM) is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices.
 
Watch Now
 
 
 
 
Killi: A New Paradigm in Consumer Data and Privacy
 
Killi (OTCQB: MYIDF) is a company driven by the evolution of consumer data and privacy. Offering compliant consumer data to brands & agencies, platforms, and data companies, Killi allows consumers to opt-in to share specific pieces of data with brands in exchange for compensation from the use of their data, democratizing data for both consumers and brands.
 
Watch Now
 
 
 
 
BioVie: Near-Term Catalysts from Phase 2 & Phase 3 Trials
 
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing transformative therapies to overcome unmet medical needs in chronic debilitating conditions. In liver disease, the Company’s Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated in a US Phase 2 study for the treatment of refractory ascites with top-line results expected in early 2022.
 
Watch Now
 
 
 
 
Virios Therapeutics: New Potential Treatment for Fibromyalgia
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
Kiromic BioPharma: AI-Driven Cancer Drug Development & Gene Editing
 
Kiromic (NASDAQ: KRBP) is revolutionizing next-generation allogenic CAR therapies for solid tumors. The Company’s proprietary target discovery engine, Diamond uses AI and a proprietary neural network to identify development targets, dramatically compressing man years and billions of drug development dollars required to develop new live drugs.
 
Watch Now
 
 
 
 
RYU Apparel: Exclusive Management Interview with Award-Winning Urban Apparel Designer
 
RYU (OTCQB: RYPPF; TSX: RYU) is expanding its footprint globally and its new wholesale initiative with major retailers is expected to further accelerate growth in 2021 and beyond. The Company is forecasted to grow revenue at a 49% CAGR through 2024.
 
Watch Now
 
 
 
 
Milestone Scientific: New Innovations in Injection Technologies
 
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical and dental applications.
 
Watch Now
 
 
 
 
Can-Fite BioPharma: Robust Pipeline Includes 75% Enrolled Phase 3 Psoriasis Program
 
Can-Fite BioPharma (NYSE Amerian:CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Home sales declined 6.6% in June for the third straight monthly decline, while U.S. consumer confidence rose to a 17-month high in July.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.